Doris Wong Sing Ee - 26 Feb 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Datuk Dr. Doris Wong Sing Ee
Issuer symbol
CYCC
Transactions as of
26 Feb 2025
Transactions value $
$0
Form type
3
Filing time
28 Feb 2025, 11:32:21
Previous filing
12 Dec 2024
Next filing
13 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYCC Common Stock 195M 26 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were purchased in a private transaction pursuant to a certain Securities Purchase Agreement, between the Reporting Person and a certain shareholder of the Issuer, for the aggregate purchase price of $6.3M.